Does DEXLANSOPRAZOLE Cause Hyperparathyroidism secondary? 382 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 382 reports of Hyperparathyroidism secondary have been filed in association with DEXLANSOPRAZOLE (Dexlansoprazole). This represents 1.6% of all adverse event reports for DEXLANSOPRAZOLE.
382
Reports of Hyperparathyroidism secondary with DEXLANSOPRAZOLE
1.6%
of all DEXLANSOPRAZOLE reports
56
Deaths
88
Hospitalizations
How Dangerous Is Hyperparathyroidism secondary From DEXLANSOPRAZOLE?
Of the 382 reports, 56 (14.7%) resulted in death, 88 (23.0%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Hyperparathyroidism secondary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEXLANSOPRAZOLE. However, 382 reports have been filed with the FAERS database.
What Other Side Effects Does DEXLANSOPRAZOLE Cause?
Chronic kidney disease (15,973)
Acute kidney injury (7,599)
Renal failure (6,618)
End stage renal disease (4,800)
Renal injury (4,320)
Tubulointerstitial nephritis (2,177)
Death (1,417)
Rebound acid hypersecretion (1,160)
Gastrooesophageal reflux disease (1,013)
Drug ineffective (859)
What Other Drugs Cause Hyperparathyroidism secondary?
ESOMEPRAZOLE (1,357)
OMEPRAZOLE (1,274)
PANTOPRAZOLE (947)
LANSOPRAZOLE (888)
RABEPRAZOLE (108)
DENOSUMAB (60)
FUROSEMIDE (49)
OMEPRAZOLE\SODIUM BICARBONATE (48)
ESOMEPRAZOLE\NAPROXEN (47)
SODIUM, DIBASIC\SODIUM, MONOBASIC (45)
Which DEXLANSOPRAZOLE Alternatives Have Lower Hyperparathyroidism secondary Risk?
DEXLANSOPRAZOLE vs DEXMEDETOMIDINE
DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE
DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE\SERDEXMETHYLPHENIDATE
DEXLANSOPRAZOLE vs DEXPANTHENOL
DEXLANSOPRAZOLE vs DEXRAZOXANE